Works by Chen, Shou-Tung


Results: 47
    1
    2
    3
    4
    5
    6
    7
    8

    Reliability of predicting low-burden (≤ 2) positive axillary lymph nodes indicating sentinel lymph node biopsy in primary operable breast cancer — a retrospective comparative study with PET/CT and breast MRI.

    Published in:
    World Journal of Surgical Oncology, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12957-023-03297-y
    By:
    • Sae-lim, Chayanee;
    • Wu, Wen-Pei;
    • Chang, Ming-Che;
    • Lai, Hung-Wen;
    • Chen, Shu-Tian;
    • Chou, Chen-Te;
    • Liao, Chiung‑Ying;
    • Huang, Hsin-I;
    • Chen, Shou-Tung;
    • Chen, Dar-Ren;
    • Hung, Che-Lun
    Publication type:
    Article
    9
    10
    11
    12
    13
    14

    Comparison of the Efficacy, Safety, and Quality of Life of Pegylated Liposomal Doxorubicin-Cyclophosphamide versus Epirubicin-Cyclophosphamide in Patients with Early-Stage HER2-Negative Breast Cancer: A Prospective, Randomized, Multicenter, Phase II Study

    Published in:
    Oncology Research & Treatment, 2024, v. 47, n. 10, p. 484, doi. 10.1159/000540369
    By:
    • Tseng, Ling-Ming;
    • Chen, Fang Ming;
    • Chen, Shou-Tung;
    • Cheng, Fiona Tsui-Fen;
    • Chao, Tsu-Yi;
    • Dai, Ming-Shen;
    • Kao, Woei-Yau;
    • Yeh, Ming-Hsin;
    • Chen, Dar-Ren;
    • Liu, Liang-Chih;
    • Wang, Hewi Chung;
    • Chang, Hong-Tai;
    • Wang, Being Whey;
    • Yu, Jyh-Cherng;
    • Chen, Shin Cheh;
    • Liao, Guo-Shiou;
    • Hou, Ming-Feng
    Publication type:
    Article
    15
    16
    17
    18
    19

    Radiotherapy versus low-dose tamoxifen following breast-conserving surgery for low-risk and estrogen receptor-positive breast ductal carcinoma in situ: an international open-label randomized non-inferiority trial (TBCC-ARO DCIS Trial).

    Published in:
    BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11291-6
    By:
    • Kuo, Sung-Hsin;
    • Tseng, Ling-Ming;
    • Chen, Shou-Tung;
    • Sagara, Yasuaki;
    • Chang, Yuan-Ching;
    • Yeh, Hsien-Tang;
    • Kuo, Yao-Lung;
    • Hung, Chih-Chiang;
    • Lu, Tzu-Pin;
    • Lee, Yi-Hsuan;
    • Toi, Masakazu;
    • Huang, Chiun-Sheng
    Publication type:
    Article
    20
    21
    22
    24

    Single-Port Three-Dimensional (3D) Videoscope-Assisted Endoscopic Nipple-Sparing Mastectomy in the Management of Breast Cancer: Technique, Clinical Outcomes, Medical Cost, Learning Curve, and Patient-Reported Aesthetic Results from 80 Preliminary Procedures

    Published in:
    Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2021, v. 28, n. 12, p. 7331, doi. 10.1245/s10434-021-09964-2
    By:
    • Lai, Hung-Wen;
    • Chen, Shou-Tung;
    • Mok, Chi Wei;
    • Chang, Yun-Ting;
    • Lin, Shih-Lung;
    • Lin, Ying-Jen;
    • Chen, Dar-Ren;
    • Kuo, Shou-Jen
    Publication type:
    Article
    25
    26

    Robotic- Versus Endoscopic-Assisted Nipple-Sparing Mastectomy with Immediate Prosthesis Breast Reconstruction in the Management of Breast Cancer: A Case–Control Comparison Study with Analysis of Clinical Outcomes, Learning Curve, Patient-Reported Aesthetic Results, and Medical Cost

    Published in:
    Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2020, v. 27, n. 7, p. 2255, doi. 10.1245/s10434-020-08223-0
    By:
    • Lai, Hung-Wen;
    • Chen, Shou-Tung;
    • Tai, Chin-Mei;
    • Lin, Shih-Lung;
    • Lin, Ying-Jen;
    • Huang, Ren-Hung;
    • Mok, Chi Wei;
    • Chen, Dar-Ren;
    • Kuo, Shou-Jen
    Publication type:
    Article
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40

    Diagnostic accuracy of pre-operative breast magnetic resonance imaging (MRI) in predicting axillary lymph node metastasis: variations in intrinsic subtypes, and strategy to improve negative predictive value—an analysis of 2473 invasive breast cancer patients

    Published in:
    Breast Cancer (13406868), 2023, v. 30, n. 6, p. 976, doi. 10.1007/s12282-023-01488-9
    By:
    • Chen, Shu-Tian;
    • Lai, Hung-Wen;
    • Chang, Julia Huei-Mei;
    • Liao, Chiung-Ying;
    • Wen, Tzu-Cheng;
    • Wu, Wen-Pei;
    • Wu, Hwa-Koon;
    • Lin, Ying-Jen;
    • Chang, Yu-Jun;
    • Chen, Shou-Tung;
    • Chen, Dar-Ren;
    • Huang, Hsin-I;
    • Hung, Che-Lun
    Publication type:
    Article
    41
    42
    43

    Analysis of the pan-Asian subgroup of patients in the NALA Trial: a randomized phase III NALA Trial comparing neratinib+capecitabine (N+C) vs lapatinib+capecitabine (L+C) in patients with HER2+metastatic breast cancer (mBC) previously treated with two or more HER2-directed regimens

    Published in:
    Breast Cancer Research & Treatment, 2021, v. 189, n. 3, p. 665, doi. 10.1007/s10549-021-06313-5
    By:
    • Dai, Ming Shen;
    • Feng, Yin Hsun;
    • Chen, Shang Wen;
    • Masuda, Norikazu;
    • Yau, Thomas;
    • Chen, Shou Tung;
    • Lu, Yen Shen;
    • Yap, Yoon Sim;
    • Ang, Peter C. S.;
    • Chu, Sung Chao;
    • Kwong, Ava;
    • Lee, Keun Seok;
    • Ow, Samuel;
    • Kim, Sung Bae;
    • Lin, Johnson;
    • Chung, Hyun Cheol;
    • Ngan, Roger;
    • Kok, Victor C.;
    • Rau, Kun Ming;
    • Sangai, Takafumi
    Publication type:
    Article
    44
    45
    46
    47